A ₹725 Cr capex bet at 69× trailing P/E — Q4 FY26 is the verdict

• The binary. After a 42% drawdown, the stock still trades at 69× trailing P/E (TTM EPS ~₹15; FY25 full-year EPS was ₹40.51 but TTM earnings compressed to ~₹39 Cr as H1 FY26 turned loss-making) — meaning the market assumes the current earnings trough is temporary. Q4 FY26 operating margin (due May–June 2026) is the sole arbiter: ≥12% validates the cyclical-trough thesis and supports a ₹1,300–1,400 recovery scenario; a print below 10% confirms structural damage and the multiple would compress toward 22×, suggesting ₹600–650.
• The Warangal test. A ₹725 Cr capex program is expanding food-grade rPET capacity from 42,000 to 132,000 TPA by FY27. Warangal — the flagship plant — still runs at only 57% utilization three years after commissioning. Food-grade rPET earns 18–22% EBITDA vs legacy RPSF's 10–11%; every 10pp of utilization improvement adds ~60bp to blended consolidated OPM. Q1 FY27 must confirm ≥80% utilization for the capex ROI to justify the debt load.
• The diagnosis dispute. The market reads the FY26 OPM collapse (14.4% → 6.1% in Q2) as moat erosion. The evidence points elsewhere: Warangal's food-grade subsidiary maintained 21–22% EBITDA margins throughout, while a 40% scrap-price spike (₹55/kg vs ₹41/kg historical norm) crushed the legacy RPSF business. Scrap prices have already normalized toward ₹45–48/kg — if Q4 OPM does not rebound, the structural-damage narrative wins by default.

Record FY25 earnings — on ₹41 Cr of cash from ₹211 Cr of profit

FY25 net profit crossed ₹100 Cr for the first time, yet operating cash flow was only ₹41 Cr — because a 153-day cash conversion cycle (inventory alone at 142 days) locks roughly ₹600 Cr in working capital at all times. The entire ₹725 Cr capex program is funded by debt that has grown 6× in five years (₹92 Cr FY20 → ₹556 Cr FY25), while ROCE has fluctuated between 8–12% over the past five years (11% FY25), below the estimated 12–14% cost of capital. Free cash flow turns positive only if Warangal utilization and inventory normalization arrive together in FY27.

A 10-point margin gap over peers — real today, with a visible expiry date

• The advantages are provable. Ganesha controls ~17–18% of India's PET bottle waste through 300-plus aggregators built over 35 years, and holds FSSAI, US FDA, and EFSA food-grade certification — one of only 6–8 approved recyclers in India. The result: 14.4% FY25 OPM vs Indorama (virgin PSF) at 4.0% and Unifi/REPREVE (US recycled polyester) at −1.7%. Three independent benchmarks confirm the feedstock-cost advantage translates into real, measurable pricing power.
• The clock is running. JB Ecotex (private) already operates 21,600 TPA of FSSAI-approved food-grade rPET — half of Warangal's capacity — and 12–15 more producers are in the approval pipeline. If 3–4 reach operational capacity by FY27–28, Ganesha's ~25% share of the approved supply pool falls toward 15%, and the food-grade pricing premium (currently ₹250–280/kg vs commodity RPSF's ₹115–130/kg) compresses 15–20%.
• RPSF has no moat. Recycled polyester staple fiber — 55% of FY25 revenue — competes with virgin PSF on cost alone. When scrap prices spike, as in Q1 FY26, margins collapse from 14% toward 6–8% regardless of certifications or customer relationships. The regulatory mandate provides no protection for this segment.